Science misinformation alarms Francis Collins as he leaves top NIH job
By Nidhi Subbaraman,
Nature
| 12. 03. 2021
The genome project leader reflects on his 12 years at the helm of a juggernaut biomedical agency, and what lies ahead.
This month, Francis Collins will step down as director of the US National Institutes of Health (NIH) after more than 12 years leading the agency, the world’s biggest public funder of biomedical research. A former head of the Human Genome Project, he championed similar bold, big-budget science efforts, such as the All of Us Project, which aims to study health data from one million people. He led the NIH under three US presidents, steered it through a roiling pandemic, and faced myriad clashes over politics and biomedical science. Collins will stay on at the NIH to continue research in his lab. He spoke to Nature about some highlights of his time at the helm, and issues facing the agency in the future.
Which achievement will you cherish most?
It’s really hard to pick one. Maybe it’s where it was possible to bring together scientists of multiple disciplines and organize a truly bold, audacious project that would simply not have happened if one just counted on it coming together passively. I’m thinking of the BRAIN Initiative. I’m thinking of what... see more
Related Articles
Image by Avopeas, CC0, via Wikimedia Commons
It is a truth almost universally acknowledged that it would be irresponsible to perform heritable human genome editing – that is, to engineer the genes and traits of future children – unless and until “there is broad societal consensus about the appropriateness of the proposed application.” But how would we know if that goal had been achieved?
The only way to determine this would be through a robust process of public deliberation. Professional scientists...
Several new opinion polls on human biotechnology issues have recently come to our attention and two of them are discussed here. As is all too typical of polling on these complex matters, it is not clear that respondents were aware of, or informed about, key background information that would shield them from drawing false conclusions, as discussed below. (For summaries of these and older opinion polls on topics related to heritable human genome editing and cloning or genetically modifying animals...
By Antonio Regalado, MIT Technology Review | 07.12.2022
A volunteer in New Zealand has become the first person to undergo DNA editing in order to lower their blood cholesterol, a step that may foreshadow wide use of the technology to prevent heart attacks.
The experiment, part of a...
By Carissa Wong, New Scientist | 07.01.2022
Photo by CDC on Unsplash
A new form of the genome-editing technique CRISPR could provide a more accurate way to edit mutations that cause genetic diseases. The approach, which was tested in fruit flies, fixes a genetic mutation on one...
